Baidu
map

上海试点免费为慢性肝炎患者家庭提供签约管理服务

2017-03-20 仇逸 新华社

记者在全国爱肝日到来之际从上海市疾控中心获悉:上海在全国率先开展慢性肝炎患者签约管理工作,已有27个试点社区免费为慢性肝炎患者家庭提供签约管理服务。

上海在全国率先开展慢性肝炎患者签约管理工作,已有27个试点社区免费为慢性肝炎患者家庭提供签约管理服务。



签约管理服务以社区卫生服务中心为基础,包括为慢性肝炎患者家庭提供免费体检、病程监测管理、疫苗免费接种、延伸处方、健康咨询和消毒指导等服务,完善慢性肝炎患者规范化管理模式,提高慢性肝炎患者的治疗依从性,降低转化成为肝硬化和肝癌的可能,并减少家庭内疾病传播。

专家介绍,我国是肝炎(尤其是乙肝)的中度流行地区。然而多数感染者不清楚自身的感染状况(尤其是丙肝),通过大众教育进一步将诊断筛查、药品治疗、疫苗接种等知识传达给肝炎患者及公众,是急需解决的问题。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1641560, encodeId=5c4116415608a, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Mon Nov 27 11:05:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807818, encodeId=0eac180e81877, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81241, encryptionId=dd7d8124144, topicName=肝炎患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 13 12:05:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674898, encodeId=f11116e489883, content=<a href='/topic/show?id=9c6b5362561' target=_blank style='color:#2F92EE;'>#慢性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53625, encryptionId=9c6b5362561, topicName=慢性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e1127134834, createdName=redcrab, createdTime=Tue Feb 13 05:05:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422174, encodeId=ca7914221e474, content=<a href='/topic/show?id=cb40e59604f' target=_blank style='color:#2F92EE;'>#签约#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75960, encryptionId=cb40e59604f, topicName=签约)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b63689109, createdName=yuanming8, createdTime=Wed Mar 22 02:05:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181451, encodeId=7dae1814517d, content=为上海点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec8c108573, createdName=ktorresjie, createdTime=Mon Mar 20 16:17:10 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1641560, encodeId=5c4116415608a, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Mon Nov 27 11:05:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807818, encodeId=0eac180e81877, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81241, encryptionId=dd7d8124144, topicName=肝炎患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 13 12:05:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674898, encodeId=f11116e489883, content=<a href='/topic/show?id=9c6b5362561' target=_blank style='color:#2F92EE;'>#慢性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53625, encryptionId=9c6b5362561, topicName=慢性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e1127134834, createdName=redcrab, createdTime=Tue Feb 13 05:05:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422174, encodeId=ca7914221e474, content=<a href='/topic/show?id=cb40e59604f' target=_blank style='color:#2F92EE;'>#签约#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75960, encryptionId=cb40e59604f, topicName=签约)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b63689109, createdName=yuanming8, createdTime=Wed Mar 22 02:05:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181451, encodeId=7dae1814517d, content=为上海点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec8c108573, createdName=ktorresjie, createdTime=Mon Mar 20 16:17:10 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1641560, encodeId=5c4116415608a, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Mon Nov 27 11:05:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807818, encodeId=0eac180e81877, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81241, encryptionId=dd7d8124144, topicName=肝炎患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 13 12:05:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674898, encodeId=f11116e489883, content=<a href='/topic/show?id=9c6b5362561' target=_blank style='color:#2F92EE;'>#慢性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53625, encryptionId=9c6b5362561, topicName=慢性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e1127134834, createdName=redcrab, createdTime=Tue Feb 13 05:05:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422174, encodeId=ca7914221e474, content=<a href='/topic/show?id=cb40e59604f' target=_blank style='color:#2F92EE;'>#签约#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75960, encryptionId=cb40e59604f, topicName=签约)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b63689109, createdName=yuanming8, createdTime=Wed Mar 22 02:05:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181451, encodeId=7dae1814517d, content=为上海点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec8c108573, createdName=ktorresjie, createdTime=Mon Mar 20 16:17:10 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1641560, encodeId=5c4116415608a, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Mon Nov 27 11:05:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807818, encodeId=0eac180e81877, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81241, encryptionId=dd7d8124144, topicName=肝炎患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 13 12:05:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674898, encodeId=f11116e489883, content=<a href='/topic/show?id=9c6b5362561' target=_blank style='color:#2F92EE;'>#慢性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53625, encryptionId=9c6b5362561, topicName=慢性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e1127134834, createdName=redcrab, createdTime=Tue Feb 13 05:05:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422174, encodeId=ca7914221e474, content=<a href='/topic/show?id=cb40e59604f' target=_blank style='color:#2F92EE;'>#签约#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75960, encryptionId=cb40e59604f, topicName=签约)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b63689109, createdName=yuanming8, createdTime=Wed Mar 22 02:05:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181451, encodeId=7dae1814517d, content=为上海点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec8c108573, createdName=ktorresjie, createdTime=Mon Mar 20 16:17:10 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-22 yuanming8
  5. [GetPortalCommentsPageByObjectIdResponse(id=1641560, encodeId=5c4116415608a, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Mon Nov 27 11:05:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807818, encodeId=0eac180e81877, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81241, encryptionId=dd7d8124144, topicName=肝炎患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 13 12:05:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674898, encodeId=f11116e489883, content=<a href='/topic/show?id=9c6b5362561' target=_blank style='color:#2F92EE;'>#慢性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53625, encryptionId=9c6b5362561, topicName=慢性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e1127134834, createdName=redcrab, createdTime=Tue Feb 13 05:05:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422174, encodeId=ca7914221e474, content=<a href='/topic/show?id=cb40e59604f' target=_blank style='color:#2F92EE;'>#签约#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75960, encryptionId=cb40e59604f, topicName=签约)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b63689109, createdName=yuanming8, createdTime=Wed Mar 22 02:05:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181451, encodeId=7dae1814517d, content=为上海点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec8c108573, createdName=ktorresjie, createdTime=Mon Mar 20 16:17:10 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-20 ktorresjie

    为上海点赞!

    0

相关资讯

综述:慢性丙肝患者的规范化治疗

       我国是一个乙型肝炎(简称乙肝)大国,临床医师及公众对乙肝的认知度、警觉度均较高,而丙型肝炎(简称丙肝)却往往被忽视,以致其早期发现率和诊断率均较低。事实上,丙肝在世界范围呈广泛流行,是欧美及日本等国家终末期肝病的最主要原因。在我国一般人群中,抗-HCV阳性率也有0.43%。丙肝病毒(HCV)感染的慢性化率(50%~85%)远

Baidu
map
Baidu
map
Baidu
map